Founder of Metahelix Life Sciences Pvt Ltd., MOgene LC and Napigen, Inc., Ganesh M. Kishore presently occupies the position of Chairman for Sentinext Therapeutics Sdn. Bhd., Chief Executive Officer of Malaysian Life Sciences Capital Fund Management Co. Ltd., Co-General Partner at MLS Capital Fund II LP (a subsidiary of Malaysian Life Sciences Capital Fund Management Co. Ltd.), President & Chief Executive Officer at K Life Sciences LLC, Managing Partner at Spruce Capital Partners LLC and Advisor at The Yield Lab Manager LLC. Ganesh M. Kishore is also Member of Institute of Food Technologists, Inc., Co-General Partner at MLS Capital Fund II LP, Member of American Association for the Advancement of Science, Member of American Society for Biochemistry & Molecular Biology, Inc., Member of American Society of Plant Physiologists and Managing Partner at Spruce Capital Management LLC and on the board of 12 other companies.

In the past Ganesh M. Kishore was Managing Director at Burrill LLC, Chief Biotechnology Officer at EIDP, Inc., Co-President-Nutrition & Consumer Sector at Monsanto Co. and Director at MOgene LC.

Dr. Kishore received a doctorate from Indian Institute of Science and a graduate degree and an undergraduate degree from the University of Mysore.